~~<i id='BCD42BBCC7'><strike id='BCD42BBCC7'><tt id='BCD42BBCC7'><pre id='BCD42BBCC7'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

knowledge

author：comprehensive 2025-09-29 01:07:22 - browse：97

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Idaho abortion case may prompt more restrictions in other states

focus

hotspot

focus

Wikipedia

hotspot

BebetoMatthews/APTurnonyourTVoropenawebbrowserthisJanuary,andyou’llbebombardedwithadsforfitnesstrack

WSS

The lessons of Aduhelm, an Alzheimer's drug that was not to be

A $475,000 price tag for a new cancer drug: crazy or meh?

Woodcock on FDA’s accelerated approval and her next chapter

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

FDA drug safety: Singulair case shows systemic surveillance flaws

New Medicare drug pricing powers could soon be upended in court

Wikipedia

knowledge

focus

Hollywood unions extend contract negotiations for actors

The SUPPORT Act is critical to fighting the opioid crisis

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Medicare proposal to cover medical devices draws a mixed reaction

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

Dobbs anniversary: the lost opportunity of abortion as health care

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

hotspot

New England Journal of Medicine addresses racist history, slavery

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Designating disabled people as health disparity population is crucial

Cybersecurity threat forces Lurie Children's to take systems offline

Fauci’s Covid grilling leads GOP to weigh foreign research rules

New Medicare drug pricing powers could soon be upended in court

hotspot

focus

Wikipedia

hotspot